Skip to main content
Top
Published in: Infection 3/2015

01-06-2015 | Original Paper

Prevalence of Brucella antibodies on a previously acute brucellosis infected population: sensitivity, specificity and predictive values of Rose Bengal and Wright standard tube agglutination tests

Authors: Panagiotis Andriopoulos, Antonia Kalogerakou, Dimitra Rebelou, Andrea Paola Rojas Gil, Sofia Zyga, Vassiliki Gennimata, Maria Tsironi

Published in: Infection | Issue 3/2015

Login to get access

Abstract

Purpose

Brucellosis is a zoonosis with worldwide distribution. The presence of antibodies after acute infection and the prevalence of positive serology in endemic area are not well documented.

Methods

Patients hospitalized with acute brucellosis were relocated 3–13 years after the initial infection. Hospital records of the initial infection were retrieved, and examination of Brucella antibodies using Rose Bengal test (RBT) and Wright standard tube agglutination (STA) test was performed.

Results

Eighty-three patients were hospitalized from 2000 to 2010; 50.6 % were farmers and 37.4 % livestock farmers. All had febrile illness and various focal complications. All had positive serology, and 82.2 % had positive blood cultures; 91.5 % were treated with streptomycin plus doxycycline. Seventy-two (86.7 %) were relocated on follow-up. Nine (12.5 %) had positive RBT and STA up to 1/320. Occupational history was associated with positive serology (p = 0.0172), and 8/9 of the positive individuals were livestock farmers (38.0 % of the livestock farmers checked). Residence, years after the infection, clinical presentation of brucellosis and treatment were not associated with serology results. Both tests had excellent sensitivity (nearly 100 %), specificity 87.5 % and excellent negative predictive value (nearly 100 %); however, positive predictive value was only 11.4 %.

Conclusions

Rapid and low-cost tests as RBT and STA are still very useful in diagnosing acute brucellosis; however, every positive test must be examined together with clinical symptoms and occupational history. The tests can be used as screening tests in endemic populations to rule out acute brucellosis.
Literature
1.
go back to reference Solera J. Update on brucellosis: therapeutic challenges. Int J Antimicrob Agents. 2010;36:S18–20.CrossRefPubMed Solera J. Update on brucellosis: therapeutic challenges. Int J Antimicrob Agents. 2010;36:S18–20.CrossRefPubMed
3.
go back to reference Al Dahouk S, Nockler K. Implications of laboratory diagnosis on brucellosis therapy. Expert Rev Anti Infect Ther. 2011;9:833–45.CrossRefPubMed Al Dahouk S, Nockler K. Implications of laboratory diagnosis on brucellosis therapy. Expert Rev Anti Infect Ther. 2011;9:833–45.CrossRefPubMed
4.
go back to reference World Health Organization. Fact sheet N173. Geneva: World Health Organization; 1997. World Health Organization. Fact sheet N173. Geneva: World Health Organization; 1997.
5.
6.
go back to reference Ulu-Kilic A, Metan G, Alp E. Clinical presentations and diagnosis of brucellosis. Recent Pat Antiinfect Drug Discov. 2013;8:34–41.CrossRefPubMed Ulu-Kilic A, Metan G, Alp E. Clinical presentations and diagnosis of brucellosis. Recent Pat Antiinfect Drug Discov. 2013;8:34–41.CrossRefPubMed
7.
go back to reference Araj GF. Update on laboratory diagnosis of human brucellosis. Int J Antimicrob Agents. 2010;36:S12–7.CrossRefPubMed Araj GF. Update on laboratory diagnosis of human brucellosis. Int J Antimicrob Agents. 2010;36:S12–7.CrossRefPubMed
8.
go back to reference European Centre for Disease Prevention and Control. Annual epidemiological report 2013. Reporting on 2011 surveillance data and 2012 epidemic intelligence data. Stockholm: ECDC; 2013. p. 66–8. European Centre for Disease Prevention and Control. Annual epidemiological report 2013. Reporting on 2011 surveillance data and 2012 epidemic intelligence data. Stockholm: ECDC; 2013. p. 66–8.
9.
go back to reference Andriopoulos P, Tsironi M, Deftereos S, Aessopos A, Assimakopoulos G. Acute brucellosis: presentation, diagnosis, and treatment of 144 cases. Int J Infect Dis. 2007;11:52–7.CrossRefPubMed Andriopoulos P, Tsironi M, Deftereos S, Aessopos A, Assimakopoulos G. Acute brucellosis: presentation, diagnosis, and treatment of 144 cases. Int J Infect Dis. 2007;11:52–7.CrossRefPubMed
10.
go back to reference Mantur BG, Amarnath SK, Patil GA, Desai AS. Clinical utility of a quantitative Rose Bengal slide agglutination test in the diagnosis of human brucellosis in an endemic region. Clin Lab. 2014;60:533–41.PubMed Mantur BG, Amarnath SK, Patil GA, Desai AS. Clinical utility of a quantitative Rose Bengal slide agglutination test in the diagnosis of human brucellosis in an endemic region. Clin Lab. 2014;60:533–41.PubMed
11.
go back to reference World Health Organisation. Brucellosis in humans and animals. Geneva: World Health Organization; 2006. p. 1–41. World Health Organisation. Brucellosis in humans and animals. Geneva: World Health Organization; 2006. p. 1–41.
12.
go back to reference Aygen B, Doganay M, Sümerkan B, Yildiz O, Kayabaşa U. Clinical manifestations, complications and treatment of brucellosis: a retrospective evaluation of 480 patients. Med Mal Infect. 2002;32:485–93.CrossRef Aygen B, Doganay M, Sümerkan B, Yildiz O, Kayabaşa U. Clinical manifestations, complications and treatment of brucellosis: a retrospective evaluation of 480 patients. Med Mal Infect. 2002;32:485–93.CrossRef
13.
go back to reference Tasova Y, Saltoglu N, Sahin G, Aksu HS. Osteoarthricular involvement of brucellosis in Turkey. Clin Rheumatol. 1999;18:214–9.CrossRefPubMed Tasova Y, Saltoglu N, Sahin G, Aksu HS. Osteoarthricular involvement of brucellosis in Turkey. Clin Rheumatol. 1999;18:214–9.CrossRefPubMed
14.
go back to reference Turan H, Serefhanoglu K, Karadeli E, Togan T, Arslan H. Osteoarticular involvement among 202 brucellosis cases identified in Central Anatolia region of Turkey. Intern Med. 2011;50:421–8.CrossRefPubMed Turan H, Serefhanoglu K, Karadeli E, Togan T, Arslan H. Osteoarticular involvement among 202 brucellosis cases identified in Central Anatolia region of Turkey. Intern Med. 2011;50:421–8.CrossRefPubMed
15.
go back to reference Aziz S, Al-Anazi AR, Al-Aska AI. A review of gastrointestinal manifestations of Brucellosis. Saudi J Gastroenterol. 2005;11:20–7.CrossRefPubMed Aziz S, Al-Anazi AR, Al-Aska AI. A review of gastrointestinal manifestations of Brucellosis. Saudi J Gastroenterol. 2005;11:20–7.CrossRefPubMed
16.
go back to reference Andriopoulos P, Tsironi M, Asimakopoulos G. Acute abdomen due to Brucella melitensis. Scand J Infect Dis. 2003;35:204–5.CrossRefPubMed Andriopoulos P, Tsironi M, Asimakopoulos G. Acute abdomen due to Brucella melitensis. Scand J Infect Dis. 2003;35:204–5.CrossRefPubMed
17.
go back to reference Akinci E, Bodur H, Cevik MA, et al. A complication of brucellosis: epididymoorchitis. Int J Infect Dis. 2006;10:171–7.CrossRefPubMed Akinci E, Bodur H, Cevik MA, et al. A complication of brucellosis: epididymoorchitis. Int J Infect Dis. 2006;10:171–7.CrossRefPubMed
18.
go back to reference Papatsoris AG, Mpadra FA, Karamouzis MV, Frangides CY. Endemic brucellar epididymo-orchitis: a 10-year experience. Int J Infect Dis. 2002;6:309–13.CrossRefPubMed Papatsoris AG, Mpadra FA, Karamouzis MV, Frangides CY. Endemic brucellar epididymo-orchitis: a 10-year experience. Int J Infect Dis. 2002;6:309–13.CrossRefPubMed
19.
go back to reference Eskazan AE, Dal MS, Kaya S, Dal T, Ayyildiz O, Soysal T. Two cases of autoimmune hemolytic anemia secondary to brucellosis: a review of hemolytic disorders in patients with brucellosis. Intern Med. 2014;53:1153–8.CrossRefPubMed Eskazan AE, Dal MS, Kaya S, Dal T, Ayyildiz O, Soysal T. Two cases of autoimmune hemolytic anemia secondary to brucellosis: a review of hemolytic disorders in patients with brucellosis. Intern Med. 2014;53:1153–8.CrossRefPubMed
20.
go back to reference Kuperman AA, Baidousi A, Nasser M, Braester A, Nassar F. Microangiopathic anemia of acute brucellosis—is it a True TTP? Mediterr J Hematol Infect Dis. 2010;2:e2010031.CrossRefPubMedCentralPubMed Kuperman AA, Baidousi A, Nasser M, Braester A, Nassar F. Microangiopathic anemia of acute brucellosis—is it a True TTP? Mediterr J Hematol Infect Dis. 2010;2:e2010031.CrossRefPubMedCentralPubMed
21.
go back to reference Young EJ, Tarry A, Genta RM, Ayden N, Gotuzzo E. Thrombocytopenic purpura associated with brucellosis: report of 2 cases and literature review. Clin Infect Dis. 2000;31:904–9.CrossRefPubMed Young EJ, Tarry A, Genta RM, Ayden N, Gotuzzo E. Thrombocytopenic purpura associated with brucellosis: report of 2 cases and literature review. Clin Infect Dis. 2000;31:904–9.CrossRefPubMed
22.
go back to reference Solera J. Treatment of human brucellosis. J Med Liban. 2000;48:255–63.PubMed Solera J. Treatment of human brucellosis. J Med Liban. 2000;48:255–63.PubMed
23.
go back to reference HasanjaniRoushan MR, Mohraz M, Hajiahmadi M, Ramzani A, Valayati AA. Efficacy of gentamicin plus doxycycline versus streptomycin plus doxycycline in the treatment of brucellosis in humans. Clin Infect Dis. 2006;42:1075–80.CrossRef HasanjaniRoushan MR, Mohraz M, Hajiahmadi M, Ramzani A, Valayati AA. Efficacy of gentamicin plus doxycycline versus streptomycin plus doxycycline in the treatment of brucellosis in humans. Clin Infect Dis. 2006;42:1075–80.CrossRef
24.
go back to reference Skalsky K, Yahav D, Bishara J, Pitlik S, Leibovici L, Paul M. Treatment of human brucellosis: systematic review and meta-analysis of randomised controlled trials. BMJ. 2008;336:701–4.CrossRefPubMedCentralPubMed Skalsky K, Yahav D, Bishara J, Pitlik S, Leibovici L, Paul M. Treatment of human brucellosis: systematic review and meta-analysis of randomised controlled trials. BMJ. 2008;336:701–4.CrossRefPubMedCentralPubMed
25.
go back to reference Keramat F, Ranjbar M, Mamani M, Hashemi SH, Zeraati F. A comparative trial of three therapeutic regimens: ciprofloxacin–rifampin, ciprofloxacin–doxycycline and doxycycline–rifampin in the treatment of brucellosis. Trop Dr. 2009;39:207–10.CrossRef Keramat F, Ranjbar M, Mamani M, Hashemi SH, Zeraati F. A comparative trial of three therapeutic regimens: ciprofloxacin–rifampin, ciprofloxacin–doxycycline and doxycycline–rifampin in the treatment of brucellosis. Trop Dr. 2009;39:207–10.CrossRef
26.
go back to reference Hashemi SH, Gachkar L, Keramat F, et al. Comparison of doxycycline–streptomycin, doxycycline–rifampin, and ofloxacin–rifampin in the treatment of brucellosis: a randomized clinical trial. Int J Infect Dis. 2012;16:e247–51.CrossRefPubMed Hashemi SH, Gachkar L, Keramat F, et al. Comparison of doxycycline–streptomycin, doxycycline–rifampin, and ofloxacin–rifampin in the treatment of brucellosis: a randomized clinical trial. Int J Infect Dis. 2012;16:e247–51.CrossRefPubMed
27.
go back to reference Mile B, Valerija K, Krsto G, Ivan V, Ilir D, Nikola L. Doxycycline–rifampin versus doxycycline–rifampin–gentamicin in treatment of human brucellosis. Trop Dr. 2012;42:13–7.CrossRef Mile B, Valerija K, Krsto G, Ivan V, Ilir D, Nikola L. Doxycycline–rifampin versus doxycycline–rifampin–gentamicin in treatment of human brucellosis. Trop Dr. 2012;42:13–7.CrossRef
28.
go back to reference Alavi SM, Alavi L. Treatment of brucellosis: a systematic review of studies in recent twenty years. Casp J Intern Med. 2013;4:636–41. Alavi SM, Alavi L. Treatment of brucellosis: a systematic review of studies in recent twenty years. Casp J Intern Med. 2013;4:636–41.
29.
go back to reference Ariza J, Corredoira J, Pallares R, et al. Characteristics of and risk factors for relapse of brucellosis in humans. Clin Infect Dis. 1995;20:1241–9.CrossRefPubMed Ariza J, Corredoira J, Pallares R, et al. Characteristics of and risk factors for relapse of brucellosis in humans. Clin Infect Dis. 1995;20:1241–9.CrossRefPubMed
30.
go back to reference Almuneef M, Memish ZA. Persistence of Brucella antibodies after successful treatment of acute brucellosis in an area of endemicity. J Clin Microbiol. 2002;40:2313.CrossRefPubMedCentralPubMed Almuneef M, Memish ZA. Persistence of Brucella antibodies after successful treatment of acute brucellosis in an area of endemicity. J Clin Microbiol. 2002;40:2313.CrossRefPubMedCentralPubMed
31.
go back to reference Mert A, Ozaras R, Tabak F, et al. The sensitivity and specificity of Brucella agglutination tests. Diagn Microbiol Infect Dis. 2003;46:241–3.CrossRefPubMed Mert A, Ozaras R, Tabak F, et al. The sensitivity and specificity of Brucella agglutination tests. Diagn Microbiol Infect Dis. 2003;46:241–3.CrossRefPubMed
32.
go back to reference Kose S, Smits HL, Abdoel TH, Ozbel Y. Prevalence of Brucella antibodies in rural and suburban communities in three provinces of Turkey: need for improved diagnosis and prevention. J Infect. 2006;53:308–14.CrossRefPubMed Kose S, Smits HL, Abdoel TH, Ozbel Y. Prevalence of Brucella antibodies in rural and suburban communities in three provinces of Turkey: need for improved diagnosis and prevention. J Infect. 2006;53:308–14.CrossRefPubMed
33.
go back to reference Ali S, Ali Q, Neubauer H, et al. Seroprevalence and risk factors associated with brucellosis as a professional hazard in Pakistan. Foodborne Pathog Dis. 2013;10:500–5.CrossRefPubMed Ali S, Ali Q, Neubauer H, et al. Seroprevalence and risk factors associated with brucellosis as a professional hazard in Pakistan. Foodborne Pathog Dis. 2013;10:500–5.CrossRefPubMed
34.
go back to reference Din AMU, Khan SA, Ahmad I, Rind R, Husain T, Shahid M, Ahmeddin S. A study on the seroprevalence of brucellosis in human and goat populations of district Bhimber, Azad Jammu and Kashmir. J Anim Plant Sci. 2013;23:13–8. Din AMU, Khan SA, Ahmad I, Rind R, Husain T, Shahid M, Ahmeddin S. A study on the seroprevalence of brucellosis in human and goat populations of district Bhimber, Azad Jammu and Kashmir. J Anim Plant Sci. 2013;23:13–8.
35.
go back to reference Abo-Shehada MN, Odeh JS, Abu-Essud M, Abuharfeil N. Seroprevalence of brucellosis among high risk people in northern Jordan. Int J Epidemiol. 1996;25:450–4.CrossRefPubMed Abo-Shehada MN, Odeh JS, Abu-Essud M, Abuharfeil N. Seroprevalence of brucellosis among high risk people in northern Jordan. Int J Epidemiol. 1996;25:450–4.CrossRefPubMed
36.
go back to reference Ahmed MO, Elmeshri SE, Abuzweda AR, et al. Seroprevalence of brucellosis in animals and human populations in the western mountains region in Libya, December 2006–January 2008. Euro Surveill. 2010;15:19625–8.PubMed Ahmed MO, Elmeshri SE, Abuzweda AR, et al. Seroprevalence of brucellosis in animals and human populations in the western mountains region in Libya, December 2006–January 2008. Euro Surveill. 2010;15:19625–8.PubMed
37.
go back to reference de Mantecon M, Los GutierrezMP, de Zarzosa M, Los P, et al. Influence of brucellosis history on serological diagnosis and evolution of patients with acute brucellosis. J Infect. 2008;57:397–403.CrossRef de Mantecon M, Los GutierrezMP, de Zarzosa M, Los P, et al. Influence of brucellosis history on serological diagnosis and evolution of patients with acute brucellosis. J Infect. 2008;57:397–403.CrossRef
38.
go back to reference Roushan MR, Amiri MJ, Laly A, Mostafazadeh A, Bijani A. Follow-up standard agglutination and 2-mercaptoethanol tests in 175 clinically cured cases of human brucellosis. Int J Infect Dis. 2010;14:e250–3.CrossRefPubMed Roushan MR, Amiri MJ, Laly A, Mostafazadeh A, Bijani A. Follow-up standard agglutination and 2-mercaptoethanol tests in 175 clinically cured cases of human brucellosis. Int J Infect Dis. 2010;14:e250–3.CrossRefPubMed
39.
go back to reference Bosilkovski M, Katerina S, Zaklina S, Ivan V. The role of Brucellacapt test for follow-up patients with brucellosis. Comp Immunol Microbiol Infect Dis. 2010;33:435–42.CrossRefPubMed Bosilkovski M, Katerina S, Zaklina S, Ivan V. The role of Brucellacapt test for follow-up patients with brucellosis. Comp Immunol Microbiol Infect Dis. 2010;33:435–42.CrossRefPubMed
40.
go back to reference Gomez MC, Nieto JA, Rosa C, et al. Evaluation of seven tests for diagnosis of human brucellosis in an area where the disease is endemic. Clin Vaccine Immunol. 2008;15:1031–3.CrossRefPubMedCentralPubMed Gomez MC, Nieto JA, Rosa C, et al. Evaluation of seven tests for diagnosis of human brucellosis in an area where the disease is endemic. Clin Vaccine Immunol. 2008;15:1031–3.CrossRefPubMedCentralPubMed
Metadata
Title
Prevalence of Brucella antibodies on a previously acute brucellosis infected population: sensitivity, specificity and predictive values of Rose Bengal and Wright standard tube agglutination tests
Authors
Panagiotis Andriopoulos
Antonia Kalogerakou
Dimitra Rebelou
Andrea Paola Rojas Gil
Sofia Zyga
Vassiliki Gennimata
Maria Tsironi
Publication date
01-06-2015
Publisher
Springer Berlin Heidelberg
Published in
Infection / Issue 3/2015
Print ISSN: 0300-8126
Electronic ISSN: 1439-0973
DOI
https://doi.org/10.1007/s15010-015-0748-z

Other articles of this Issue 3/2015

Infection 3/2015 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.